GlassScriptPhysician profile
Shoaib A Shakeel
NPI 1790105443
$4,706.53
in general payments reported to CMS, 2019-2025
22 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $235 · 2021: $155 · 2022: $53.99 · 2023: $72.65 · 2024: $3,407 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $763 · Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $763.04 |
| Food and Beverage | $636.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,280.03 | 2024 | |
| Inari Medical, INC. | $195.41 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $189.50 | 2019-2024 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.42 | 2019-2020 | |
| Ethicon INC. | $124.40 | 2021 | |
| Pulmonx Corporation | $120.30 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $118.88 | 2019-2025 | Nucala |
| Grifols USA, LLC | $104.93 | 2020-2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $67.81 | 2019-2024 | Yupelri |
| Insmed, INC. | $47.14 | 2019-2025 | Arikayce |
| Pfizer INC. | $39.66 | 2025 | |
| Ani Pharmaceuticals, INC. | $30.64 | 2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $29.99 | 2019 | |
| Baxter Healthcare | $26.56 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $20.19 | 2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $19.83 | 2022 | |
| Covis Pharma Gmbh | $18.73 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.63 | 2020 | |
| Philips North America LLC | $18.48 | 2024 | (Ak6) Vest Therapy |
| Gilead Sciences, INC. | $17.43 | 2023 | |
| Jazz Pharmaceuticals INC. | $16.35 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoaib Shakeel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.